You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neuroendocrine tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Not yet recruiting
  • Neuroendocrine Tumors
    • San Francisco, California
      Power Life Sciences
    Jul 21, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • [212Pb] VMT-α-NET
    • [203Pb] VMT-α-NET SPECT/CT
    • Iowa City, Iowa
      Holden Comprehensive Cancer Center at the University of Iowa
    Nov 30, 2023

    Neuroendocrine Tumor Trial in Beijing (Al18F-octreotide)

    Recruiting
    • Neuroendocrine Tumor
    • Beijing, Chao Yang, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Feb 19, 2023

    Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • +6 more
    • (no location specified)
    Aug 4, 2023

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

    Not yet recruiting
    • Neuroendocrine Tumors
    • +8 more
    • Iowa City, Iowa
    • +1 more
    Nov 23, 2022

    Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

    Completed
    • Recurrent Neuroendocrine Tumor
    • Metastatic Neuroendocrine Tumor
    • Cleveland, Ohio
      Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
    Dec 1, 2022

    Development of New Personalised 3D Preclinical Models of

    Recruiting
    • Pancreatic Neuroendocrine Tumor
      • Milan, MI, Italy
        IRCCS San Raffele Institute
      Nov 2, 2023

      Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

      Completed
      • Pancreatic Neuroendocrine Tumor G2
      • Octreotide LAR
      • (no location specified)
      Oct 17, 2023

      Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

      Not yet recruiting
      • Adrenal Cortical Carcinoma
      • +3 more
      • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
      Nov 19, 2023

      Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

      Not yet recruiting
      • Advanced Gastroenteropancreatic Neuroendocrine Tumor
      • (no location specified)
      Oct 16, 2023

      Surufatinib in G3 Neuroendocrine Tumors

      Not yet recruiting
      • Neuroendocrine Tumor Grade 3
      • (no location specified)
      Aug 2, 2023

      Multi-dimensional Fragmentomic Assay for Early Detection of

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumor
      • Fragmentomic profiles of plasma cfDNA
      • (no location specified)
      Apr 27, 2023

      Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

      Not yet recruiting
      • Metastatic Pancreatic Neuroendocrine Tumor
      • +4 more
      • Biospecimen Collection
      • +5 more
      • (no location specified)
      Jan 14, 2023

      Gastroenteropancreatic Neuroendocrine Tumours

      Recruiting
      • Gastroenteropancreatic Neuroendocrine Tumor
      • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
      • Milano, Italy
        Irccs San Raffaele
      Nov 24, 2023

      Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

      Enrolling by invitation
      • Neuroendocrine Tumor Grade 2
      • Neuroendocrine Tumor Grade 1
      • Iowa City, Iowa
        The University of Iowa
      Dec 9, 2022

      Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning

      Recruiting
      • Nonfunctional Pancreatic Neuroendocrine Tumor
      • +2 more
      • EUS-guided ethanol ablation
      • EUS-guided lauromacrogol ablation
      • Nanning, Guangxi, China
        First Affiliated Hospital of Guangxi Medical University
      Sep 30, 2022

      Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

      Not yet recruiting
      • Neuroendocrine Tumors
      • Somatostatin Receptor-positive Neuroendocrine Tumor
      • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
      • +3 more
      • Madison, Wisconsin
        University of Wisconsin - Madison
      Nov 2, 2023

      Collect Somatuline® Injector Device Preferences of Patients

      Not yet recruiting
      • Neuroendocrine Tumors
        • (no location specified)
        Jun 19, 2023

        Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

        Recruiting
        • Locally Advanced Neuroendocrine Neoplasm
        • Metastatic Neuroendocrine Neoplasm
        • Placebo Administration
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 31, 2023

        68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

        Recruiting
        • Neuroendocrine Tumor Carcinoid
        • +2 more
          • Milan, Italy
            IRCCS Istituto Europeo di Oncologia S.r.l.
          Jul 8, 2022

          Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

          Withdrawn
          • Gastro-enteropancreatic Neuroendocrine Tumor
          • (no location specified)
          Feb 17, 2022

          Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

          Not yet recruiting
          • Advanced Gastroenteropancreatic Neuroendocrine Tumor
          • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
          • long-acting Octreotide.
          • (no location specified)
          May 22, 2023

          Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic

          Recruiting
          • Hepatocarcinoma
          • Pancreatic Tumor
          • Hepatocellular carcinoma
          • +2 more
          • Clichy, France
            Hôpital Beaujon
          Mar 20, 2023